Monocyte chemoattractant protein (MCP)-1, a proinflammatory chemokine, recently has been reported to be up-regulated in many models of neuronal damage, including infection, axotomy, Alzheimer's (mouse model), excitotoxicity, and traumatic brain injury. A role for this chemokine in toxic injuries of the CNS has not been established, therefore, we evaluated the expression of MCP-1 following neuronal damage resulting from exposure to the prototypical hippocampal toxicant, TMT. Althought mediators of inflammation (TNF, IL-1, etc) are linked to neurological disease states, they are not, in general, associated with hippocampal damage and gliosis resulting from exposure to TMT. In the present study, however, we found a marked increase in the expression of MCP-1 after exposure of rats to TMT (8 mg/kg, i.p.). MCP-1 mRNA (assessed by RT-PCR) was elevated as early as 3 days post TMT, with peak increases (450%) observed at 21 days; the last timepoint studied. These effects of TMT on MCP-1 mRNA were confirmed by real-time Taqman analysis and were associated with increases in MCP-1 assessed by immunoblot and ELISA. Glucocorticoids (drinking water) suppressed the expression of MCP-1 without affecting TMT-induced gliosis; therefore, MCP-1 does not appear to mediate TMT-induced damage. Although the blood-brain barrier remained intact after TMT and blood could be ruled out as a source of MCP-1 expression in the brain, a source in the periphery for induction of brain MCP-1 cannot be excluded. This latter view is supported by the fact that systematic LPS (0.5 mg/kg) increases hippocampal MCP-1 mRNA in the absence of neuronal damage. MCP-1 may be a sensitive biomarker of neural injury but signals from peripheral target organs cannot be ruled out as sources of signals including brain expression of this chemokine.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.